Results 131 to 140 of about 23,882 (215)

Antimicrobial stewardship and the antibiotic market: why "Reserve" drugs require new economic models. [PDF]

Ther Adv Drug Saf
Castellana E, Tarozzo A, Viglianti R, Molon C, Chiappetta MR.   +4 more
europepmc   +1 more source

The Fast, the Steady and the Tenacious: Funding Pathways for Circular Start‐Ups

Business Strategy and the Environment, EarlyView.
ABSTRACT Circular start‐ups (CSUs) are critical for unlocking the circular economy, yet they face persistent barriers in accessing finance. Despite growing interest from policymakers and financing institutions, little empirical evidence explains how these ventures pursue and secure funding.
Pilar Mejía‐Vélez, Wim Van Opstal, Christina Bidmon, Saskia Manshoven, Julian Kirchherr   +4 more
wiley   +1 more source

The Determinants of Profitability in Iran's Pharmaceutical Industry: A Panel Data Analysis. [PDF]

Med J Islam Repub Iran
Zare M, Hadian M, Tahmasebi A.
europepmc   +1 more source

Does Stakeholder Pressure Promote Green Innovations and Performance of Agribusiness Companies?

Business Strategy and the Environment, EarlyView.
ABSTRACT The sustainability of agribusiness companies is guided by multiple, sometimes paradoxical, interests. Green innovation is strategic for sustainable development; however, literature shows inconsistencies regarding its impact on environmental and economic‐financial performance.
Vanderlei dos Santos, Ilse Maria Beuren, Adrian Odelli, Rodrigo Rengel, Daniele Cristina Bernd   +4 more
wiley   +1 more source

The Effects of Compulsory Licensing: A Case Study of HIV Drugs. [PDF]

Health Econ
Martin-Bassols N, Serra-Burriel M, Vokinger KN.   +2 more
europepmc   +1 more source

Artificial Intelligence–Driven and Digital Practices for Circular Business and Finance: Insights for Advancing Hubs for Circularity

Business Strategy and the Environment, EarlyView.
ABSTRACT The emerging concept of Hubs for Circularity (H4Cs) presents an opportunity to create collaborative, self‐sustaining regional industrial ecosystems that drive circular economy transitions at scale. However, the operationalisation of H4Cs faces financial, organisational and data‐driven challenges.
Aditya Tripathi, Marcos R. Machado, Laura Spierdijk, Devrim Murat Yazan   +3 more
wiley   +1 more source

One rule does not fit all: Deviations from universality in human mobility modeling. [PDF]

PNAS Nexus
Napoli L, Karsai M, Moro E.
europepmc   +1 more source

Investor Perceptions of Climate Policy: Insights From the US Inflation Reduction Act

Business Strategy and the Environment, EarlyView.
ABSTRACT This paper provides the first event study evidence on how the Inflation Reduction Act's (IRA) dedicated climate provisions reshaped equity valuations in the US carbon‐intensive sectors. Focusing on environmentally sensitive industries (ESI), we analyze cumulative abnormal returns around the four key IRA milestones in 2022–2023.
Laura Ferraro, Arati Kale, Devendra Kale, Franco Ernesto Rubino   +3 more
wiley   +1 more source

E-Cigarette Directory Laws, Sales, and Product Availability From 3 Early-Adopting US States.

JAMA Netw Open
Ali FRM, Mahoney M, Seaman Jones EL, Tynan MA, Marynak K.   +4 more
europepmc   +1 more source

Rethinking responses to over-the-counter drug overdose among young people in Japan: Toward a low-threshold support architecture. [PDF]

Glob Health Med
Ujihara M, Iwasawa A, Watanabe M.
europepmc   +1 more source